Replies to post #148130 on Biotech Values

[jq1234]

It was a merger agreement. Inamed was valued higher than MRX at the time if I remember correctly.

[DewDiligence]

Did Inamed try to buy MRX or was it the other way around?

The other way around; from the 2005 PR announcing the deal (http://www.businesswire.com/news/home/20050321005442/en/Medicis-Inamed-Agree-Merge-Combination-Create-Global ):

Under the terms of the transaction…Inamed stockholders will receive 1.4205 shares of Medicis common stock and $30 in cash for each share of Inamed common stock. Based on Medicis' closing price on March 18, 2005, and the number of Inamed shares outstanding, the merger consideration represents $75 in value per Inamed share, or a total equity value of approximately $2.8 billion.

MRX was clearly the acquiring company, so Inamed is not the answer to the quiz in #msg-79192069.